Industry News
Researchers Identify Genetic Mutation Responsible For Most Cases Of Waldenstrom's Macroglobulinemia
Dec 13, 2011
Scientists at Dana-Farber Cancer Institute have identified a gene mutation that underlies the vast majority of cases of Waldenstrom's macroglobulinemia, a rare form of lymphoma that has eluded all previous efforts to find a genetic cause. The research (abstracts 261, 300, 434 and 597), to be presented at the American Society of Hematology's 2011 annual meeting on Monday, Dec. 12 at 2:45 p.m... Read More
AML Patients Have High Response Rate With Vorinostat Added To Treatment
Dec 13, 2011
Adding a drug that activates genes to frontline combination therapy for acute myeloid leukemia resulted in an 85 percent remission rate after initial treatment, researchers at The University of Texas MD Anderson Cancer Center reported at the 53rd Annual Meeting of the American Society of Hematology... Read More
"Twinning" U.S.-Based And Rwandan Physicians Improves Lymphoma Outcomes In Children
Dec 13, 2011
In an African county lacking any specialists in children's cancers, a team approach that "twins" Rwandan physicians with Boston-based pediatric oncologists has shown it can deliver expert, curative care to young patients stricken with lymphoma... Read More
Brain Tumor Chemotherapy Resistance Prediction
Dec 13, 2011
Glioblastoma multiforme (GBM) is the most common and lethal of all human brain tumors that originate in the brain. For most patients, treatment involves surgery followed by both radiation therapy and chemotherapy with temozolomide. However, many GBMs are resistant to the effects of temozolomide... Read More
Childhood Cancer Survivors' Exposure To Chemotherapy, Radiation Does Not Increase Risk Of Birth Defects In Their Children
Dec 13, 2011
A large, retrospective study shows that children of childhood cancer survivors who received prior treatment involving radiation to testes or ovaries and/or chemotherapy with alkylating agents do not have an increased risk for birth defects compared to children of survivors who did not have such cancer treatment... Read More
Dana-Farber Offers Healthy Holiday Recipes And Food Tips To Fight Cancer With Your Fork This Holiday Season
Dec 13, 2011
The holidays are in full swing and festive food is everywhere. Some are naughty, some are nice, and some may even help fight cancer. "While these so-called holiday foods are delicious to eat, they can also have the added bonus of containing cancer-preventing nutrients," says Stephanie Meyers, MS, RD/LDN, a nutritionist at Dana-Farber Cancer Institute in Boston... Read More
Gene Inheritance Patterns Influence Age Of Diagnosis In BRCA Families
Dec 13, 2011
Women who inherit the cancer genes BRCA1 or BRCA2 from their paternal lineage may get a diagnosis a decade earlier than those women who carry the cancer genes from their mother and her ancestors, according to a new study by researchers at the North Shore-LIJ Health System's Monter Cancer Center in Lake Success, NY. The findings were reported at the San Antonio Breast Cancer Symposium... Read More
Increasing Number Of Imaging Visits Faced By Breast Cancer Patients Before Surgery
Dec 13, 2011
Breast cancer patients frequently undergo imaging like mammograms or ultrasounds between their first breast cancer-related doctor visit and surgery to remove the tumor. Evaluations of these scans help physicians understand a person's disease and determine the best course of action... Read More
Immune System Repaired In Leukemia Patients Following Chemotherapy
Dec 13, 2011
A new treatment using leukemia patients' own infection-fighting cells appears to protect them from infections and cancer recurrence following treatment with fludarabine-based chemotherapy, according to new research from the Perelman School of Medicine at the University of Pennsylvania... Read More
B Cell Receptor Inhibitor Causes Chronic Lymphocytic Leukemia Remission
Dec 13, 2011
PCI-32765 applies molecularly aimed attack to disease usually treated with chemotherapy combinations A new, targeted approach to treating chronic lymphocytic leukemia has produced durable remissions in a Phase I/II clinical trial for patients with relapsed or resistant disease, investigators report at the 53rd Annual Meeting of the American Society of Hematology... Read More
Previous Page Next Page